Abstract
2,6-Dimethyl- and 2,6-dichlorophenoxyethyl trimethylammonium bromides, together with their alpha and beta methyl analogs were synthesized and studied for autonomic effects.
Muscarinic stimulant activity of the unsubstituted compounds was reduced by alpha methylation and eliminated by beta methylation.
Sympathetic inhibitor potency, revealed by relaxation of the nictitating membrane in unanesthetized cats, was reduced by alpha methylation.
Tests with autonomic drugs and nerve action potential recordings indicated that the characteristic inhibition produced by the unsubstituted and the beta-substituted congeners is selective for the terminal sympathetic nerve endings.
Footnotes
- Received October 10, 1959.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
A SERIES OF 2,6-DISUBSTITUTED PHENOXYETHYL AMMONIUM BROMIDES WITH TRUE SYMPATHOLYTIC PROPERTIES
